nodes	percent_of_prediction	percent_of_DWPC	metapath
Nicotine—CHAT—amyotrophic lateral sclerosis	0.551	1	CbGaD
Nicotine—CYP1A1—Riluzole—amyotrophic lateral sclerosis	0.158	0.691	CbGbCtD
Nicotine—CYP1A2—Riluzole—amyotrophic lateral sclerosis	0.0708	0.309	CbGbCtD
Nicotine—Motor dysfunction—Riluzole—amyotrophic lateral sclerosis	0.00885	0.122	CcSEcCtD
Nicotine—CHRNB3—pons—amyotrophic lateral sclerosis	0.00694	0.0979	CbGeAlD
Nicotine—CHAT—cranial nerve—amyotrophic lateral sclerosis	0.00487	0.0687	CbGeAlD
Nicotine—CHAT—pons—amyotrophic lateral sclerosis	0.00481	0.0679	CbGeAlD
Nicotine—CHAT—peripheral nervous system—amyotrophic lateral sclerosis	0.0032	0.0451	CbGeAlD
Nicotine—CHRNB3—hindbrain—amyotrophic lateral sclerosis	0.0027	0.038	CbGeAlD
Nicotine—CHRNA9—embryo—amyotrophic lateral sclerosis	0.00255	0.0359	CbGeAlD
Nicotine—CHAT—nerve—amyotrophic lateral sclerosis	0.0025	0.0352	CbGeAlD
Nicotine—Gastric ulcer—Riluzole—amyotrophic lateral sclerosis	0.00221	0.0306	CcSEcCtD
Nicotine—Completed suicide—Riluzole—amyotrophic lateral sclerosis	0.00218	0.0302	CcSEcCtD
Nicotine—Tooth disorder—Riluzole—amyotrophic lateral sclerosis	0.00198	0.0274	CcSEcCtD
Nicotine—CHAT—hindbrain—amyotrophic lateral sclerosis	0.00187	0.0264	CbGeAlD
Nicotine—Apathy—Riluzole—amyotrophic lateral sclerosis	0.0018	0.0249	CcSEcCtD
Nicotine—Flat affect—Riluzole—amyotrophic lateral sclerosis	0.00178	0.0246	CcSEcCtD
Nicotine—CHRNB3—brainstem—amyotrophic lateral sclerosis	0.00155	0.0218	CbGeAlD
Nicotine—CHRNA4—peripheral nervous system—amyotrophic lateral sclerosis	0.00138	0.0195	CbGeAlD
Nicotine—Respiratory failure—Riluzole—amyotrophic lateral sclerosis	0.00131	0.0181	CcSEcCtD
Nicotine—Coordination abnormal—Riluzole—amyotrophic lateral sclerosis	0.00131	0.0181	CcSEcCtD
Nicotine—CHRNA6—brainstem—amyotrophic lateral sclerosis	0.00129	0.0182	CbGeAlD
Nicotine—Hiccups—Riluzole—amyotrophic lateral sclerosis	0.00128	0.0178	CcSEcCtD
Nicotine—Abnormal dreams—Riluzole—amyotrophic lateral sclerosis	0.00127	0.0176	CcSEcCtD
Nicotine—Fluid retention—Riluzole—amyotrophic lateral sclerosis	0.00122	0.0169	CcSEcCtD
Nicotine—Cramps of lower extremities—Riluzole—amyotrophic lateral sclerosis	0.00118	0.0163	CcSEcCtD
Nicotine—Mental disability—Riluzole—amyotrophic lateral sclerosis	0.00111	0.0154	CcSEcCtD
Nicotine—Ear pain—Riluzole—amyotrophic lateral sclerosis	0.00109	0.0151	CcSEcCtD
Nicotine—CHRNA4—nerve—amyotrophic lateral sclerosis	0.00108	0.0152	CbGeAlD
Nicotine—CHAT—brainstem—amyotrophic lateral sclerosis	0.00107	0.0151	CbGeAlD
Nicotine—Amnesia—Riluzole—amyotrophic lateral sclerosis	0.000992	0.0137	CcSEcCtD
Nicotine—Increased appetite—Riluzole—amyotrophic lateral sclerosis	0.000992	0.0137	CcSEcCtD
Nicotine—Atrial fibrillation—Riluzole—amyotrophic lateral sclerosis	0.000983	0.0136	CcSEcCtD
Nicotine—Arthritis—Riluzole—amyotrophic lateral sclerosis	0.000959	0.0133	CcSEcCtD
Nicotine—Cardiac failure—Riluzole—amyotrophic lateral sclerosis	0.000955	0.0132	CcSEcCtD
Nicotine—Affect lability—Riluzole—amyotrophic lateral sclerosis	0.000917	0.0127	CcSEcCtD
Nicotine—Migraine—Riluzole—amyotrophic lateral sclerosis	0.000917	0.0127	CcSEcCtD
Nicotine—CHRNA5—nervous system—amyotrophic lateral sclerosis	0.000892	0.0126	CbGeAlD
Nicotine—Mood swings—Riluzole—amyotrophic lateral sclerosis	0.000883	0.0122	CcSEcCtD
Nicotine—CHRNA5—central nervous system—amyotrophic lateral sclerosis	0.000858	0.0121	CbGeAlD
Nicotine—SLC22A3—tongue—amyotrophic lateral sclerosis	0.000851	0.012	CbGeAlD
Nicotine—CHRNB3—nervous system—amyotrophic lateral sclerosis	0.00081	0.0114	CbGeAlD
Nicotine—CHRNA4—hindbrain—amyotrophic lateral sclerosis	0.000808	0.0114	CbGeAlD
Nicotine—MAOB—nerve—amyotrophic lateral sclerosis	0.000806	0.0114	CbGeAlD
Nicotine—Influenza—Riluzole—amyotrophic lateral sclerosis	0.000805	0.0111	CcSEcCtD
Nicotine—Dysphagia—Riluzole—amyotrophic lateral sclerosis	0.000805	0.0111	CcSEcCtD
Nicotine—CHRNB3—central nervous system—amyotrophic lateral sclerosis	0.000779	0.011	CbGeAlD
Nicotine—Bronchitis—Riluzole—amyotrophic lateral sclerosis	0.000774	0.0107	CcSEcCtD
Nicotine—Abdominal discomfort—Riluzole—amyotrophic lateral sclerosis	0.000772	0.0107	CcSEcCtD
Nicotine—CHRNB3—cerebellum—amyotrophic lateral sclerosis	0.000762	0.0107	CbGeAlD
Nicotine—CHAT—medulla oblongata—amyotrophic lateral sclerosis	0.000747	0.0105	CbGeAlD
Nicotine—Weight increased—Riluzole—amyotrophic lateral sclerosis	0.000733	0.0101	CcSEcCtD
Nicotine—Stomatitis—Riluzole—amyotrophic lateral sclerosis	0.0007	0.00969	CcSEcCtD
Nicotine—MAOA—nerve—amyotrophic lateral sclerosis	0.000688	0.0097	CbGeAlD
Nicotine—CHRNA5—brain—amyotrophic lateral sclerosis	0.000682	0.00961	CbGeAlD
Nicotine—Epistaxis—Riluzole—amyotrophic lateral sclerosis	0.000677	0.00937	CcSEcCtD
Nicotine—CHRNA6—nervous system—amyotrophic lateral sclerosis	0.000676	0.00953	CbGeAlD
Nicotine—Sinusitis—Riluzole—amyotrophic lateral sclerosis	0.000674	0.00932	CcSEcCtD
Nicotine—CHAT—spinal cord—amyotrophic lateral sclerosis	0.000666	0.00939	CbGeAlD
Nicotine—CHRNA6—central nervous system—amyotrophic lateral sclerosis	0.000651	0.00918	CbGeAlD
Nicotine—Rhinitis—Riluzole—amyotrophic lateral sclerosis	0.000646	0.00894	CcSEcCtD
Nicotine—Hypoaesthesia—Riluzole—amyotrophic lateral sclerosis	0.000641	0.00888	CcSEcCtD
Nicotine—Pharyngitis—Riluzole—amyotrophic lateral sclerosis	0.00064	0.00885	CcSEcCtD
Nicotine—CHRNA6—cerebellum—amyotrophic lateral sclerosis	0.000636	0.00897	CbGeAlD
Nicotine—Oedema peripheral—Riluzole—amyotrophic lateral sclerosis	0.000635	0.00879	CcSEcCtD
Nicotine—CHRNB3—brain—amyotrophic lateral sclerosis	0.000619	0.00873	CbGeAlD
Nicotine—CHRNB4—nervous system—amyotrophic lateral sclerosis	0.000614	0.00865	CbGeAlD
Nicotine—MAOB—hindbrain—amyotrophic lateral sclerosis	0.000604	0.00852	CbGeAlD
Nicotine—Cardiac disorder—Riluzole—amyotrophic lateral sclerosis	0.000598	0.00828	CcSEcCtD
Nicotine—CHRNB4—central nervous system—amyotrophic lateral sclerosis	0.000591	0.00833	CbGeAlD
Nicotine—Immune system disorder—Riluzole—amyotrophic lateral sclerosis	0.000582	0.00806	CcSEcCtD
Nicotine—Mediastinal disorder—Riluzole—amyotrophic lateral sclerosis	0.000581	0.00804	CcSEcCtD
Nicotine—Arrhythmia—Riluzole—amyotrophic lateral sclerosis	0.000576	0.00797	CcSEcCtD
Nicotine—Mental disorder—Riluzole—amyotrophic lateral sclerosis	0.000565	0.00782	CcSEcCtD
Nicotine—CHAT—nervous system—amyotrophic lateral sclerosis	0.000561	0.00792	CbGeAlD
Nicotine—Flatulence—Riluzole—amyotrophic lateral sclerosis	0.000553	0.00765	CcSEcCtD
Nicotine—Tension—Riluzole—amyotrophic lateral sclerosis	0.000551	0.00762	CcSEcCtD
Nicotine—Dysgeusia—Riluzole—amyotrophic lateral sclerosis	0.000549	0.0076	CcSEcCtD
Nicotine—Nervousness—Riluzole—amyotrophic lateral sclerosis	0.000545	0.00754	CcSEcCtD
Nicotine—Back pain—Riluzole—amyotrophic lateral sclerosis	0.000543	0.00751	CcSEcCtD
Nicotine—CHAT—central nervous system—amyotrophic lateral sclerosis	0.00054	0.00762	CbGeAlD
Nicotine—Muscle spasms—Riluzole—amyotrophic lateral sclerosis	0.000539	0.00747	CcSEcCtD
Nicotine—CHAT—cerebellum—amyotrophic lateral sclerosis	0.000528	0.00745	CbGeAlD
Nicotine—Tremor—Riluzole—amyotrophic lateral sclerosis	0.000526	0.00728	CcSEcCtD
Nicotine—Ill-defined disorder—Riluzole—amyotrophic lateral sclerosis	0.000521	0.00721	CcSEcCtD
Nicotine—CHRNB2—medulla oblongata—amyotrophic lateral sclerosis	0.000517	0.00729	CbGeAlD
Nicotine—CHRNA6—brain—amyotrophic lateral sclerosis	0.000516	0.00728	CbGeAlD
Nicotine—Agitation—Riluzole—amyotrophic lateral sclerosis	0.000516	0.00714	CcSEcCtD
Nicotine—MAOA—hindbrain—amyotrophic lateral sclerosis	0.000515	0.00727	CbGeAlD
Nicotine—Angioedema—Riluzole—amyotrophic lateral sclerosis	0.000513	0.0071	CcSEcCtD
Nicotine—Malaise—Riluzole—amyotrophic lateral sclerosis	0.000506	0.007	CcSEcCtD
Nicotine—Vertigo—Riluzole—amyotrophic lateral sclerosis	0.000504	0.00698	CcSEcCtD
Nicotine—Syncope—Riluzole—amyotrophic lateral sclerosis	0.000503	0.00696	CcSEcCtD
Nicotine—Palpitations—Riluzole—amyotrophic lateral sclerosis	0.000496	0.00686	CcSEcCtD
Nicotine—Loss of consciousness—Riluzole—amyotrophic lateral sclerosis	0.000493	0.00683	CcSEcCtD
Nicotine—Cough—Riluzole—amyotrophic lateral sclerosis	0.00049	0.00678	CcSEcCtD
Nicotine—Convulsion—Riluzole—amyotrophic lateral sclerosis	0.000486	0.00673	CcSEcCtD
Nicotine—Hypertension—Riluzole—amyotrophic lateral sclerosis	0.000484	0.0067	CcSEcCtD
Nicotine—Myalgia—Riluzole—amyotrophic lateral sclerosis	0.000478	0.00661	CcSEcCtD
Nicotine—Chest pain—Riluzole—amyotrophic lateral sclerosis	0.000478	0.00661	CcSEcCtD
Nicotine—Arthralgia—Riluzole—amyotrophic lateral sclerosis	0.000478	0.00661	CcSEcCtD
Nicotine—Anxiety—Riluzole—amyotrophic lateral sclerosis	0.000476	0.00659	CcSEcCtD
Nicotine—Discomfort—Riluzole—amyotrophic lateral sclerosis	0.000472	0.00653	CcSEcCtD
Nicotine—CHRNB4—brain—amyotrophic lateral sclerosis	0.000469	0.00662	CbGeAlD
Nicotine—Dry mouth—Riluzole—amyotrophic lateral sclerosis	0.000467	0.00647	CcSEcCtD
Nicotine—CHRNA4—brainstem—amyotrophic lateral sclerosis	0.000463	0.00653	CbGeAlD
Nicotine—Confusional state—Riluzole—amyotrophic lateral sclerosis	0.000462	0.00639	CcSEcCtD
Nicotine—CHRNB2—spinal cord—amyotrophic lateral sclerosis	0.000461	0.0065	CbGeAlD
Nicotine—Oedema—Riluzole—amyotrophic lateral sclerosis	0.000458	0.00634	CcSEcCtD
Nicotine—Anaphylactic shock—Riluzole—amyotrophic lateral sclerosis	0.000458	0.00634	CcSEcCtD
Nicotine—Shock—Riluzole—amyotrophic lateral sclerosis	0.000451	0.00624	CcSEcCtD
Nicotine—Nervous system disorder—Riluzole—amyotrophic lateral sclerosis	0.000449	0.00622	CcSEcCtD
Nicotine—Tachycardia—Riluzole—amyotrophic lateral sclerosis	0.000447	0.00619	CcSEcCtD
Nicotine—Hyperhidrosis—Riluzole—amyotrophic lateral sclerosis	0.000443	0.00613	CcSEcCtD
Nicotine—CHAT—brain—amyotrophic lateral sclerosis	0.000429	0.00605	CbGeAlD
Nicotine—Hypotension—Riluzole—amyotrophic lateral sclerosis	0.000428	0.00592	CcSEcCtD
Nicotine—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.000417	0.00577	CcSEcCtD
Nicotine—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.000414	0.00573	CcSEcCtD
Nicotine—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.000411	0.00569	CcSEcCtD
Nicotine—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.000408	0.00565	CcSEcCtD
Nicotine—SLC22A3—embryo—amyotrophic lateral sclerosis	0.000408	0.00576	CbGeAlD
Nicotine—Somnolence—Riluzole—amyotrophic lateral sclerosis	0.000407	0.00563	CcSEcCtD
Nicotine—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.000403	0.00558	CcSEcCtD
Nicotine—Gastrointestinal disorder—Riluzole—amyotrophic lateral sclerosis	0.000395	0.00547	CcSEcCtD
Nicotine—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.000395	0.00546	CcSEcCtD
Nicotine—Pain—Riluzole—amyotrophic lateral sclerosis	0.000392	0.00542	CcSEcCtD
Nicotine—Constipation—Riluzole—amyotrophic lateral sclerosis	0.000392	0.00542	CcSEcCtD
Nicotine—CHRNB2—nervous system—amyotrophic lateral sclerosis	0.000388	0.00547	CbGeAlD
Nicotine—MAOB—embryo—amyotrophic lateral sclerosis	0.000378	0.00533	CbGeAlD
Nicotine—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.000377	0.00522	CcSEcCtD
Nicotine—CHRNA3—nervous system—amyotrophic lateral sclerosis	0.000376	0.00531	CbGeAlD
Nicotine—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.000374	0.00518	CcSEcCtD
Nicotine—CHRNB2—central nervous system—amyotrophic lateral sclerosis	0.000374	0.00527	CbGeAlD
Nicotine—CHRNB2—cerebellum—amyotrophic lateral sclerosis	0.000365	0.00515	CbGeAlD
Nicotine—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.000364	0.00504	CcSEcCtD
Nicotine—CHRNA3—central nervous system—amyotrophic lateral sclerosis	0.000362	0.00511	CbGeAlD
Nicotine—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.000362	0.00501	CcSEcCtD
Nicotine—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.000362	0.00501	CcSEcCtD
Nicotine—CHRNA3—cerebellum—amyotrophic lateral sclerosis	0.000354	0.005	CbGeAlD
Nicotine—CHRNA2—nervous system—amyotrophic lateral sclerosis	0.00035	0.00494	CbGeAlD
Nicotine—MAOB—brainstem—amyotrophic lateral sclerosis	0.000346	0.00488	CbGeAlD
Nicotine—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.000337	0.00467	CcSEcCtD
Nicotine—CHRNA2—central nervous system—amyotrophic lateral sclerosis	0.000337	0.00475	CbGeAlD
Nicotine—CHRNA2—cerebellum—amyotrophic lateral sclerosis	0.000329	0.00464	CbGeAlD
Nicotine—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.000329	0.00455	CcSEcCtD
Nicotine—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.000324	0.00448	CcSEcCtD
Nicotine—MAOA—embryo—amyotrophic lateral sclerosis	0.000322	0.00454	CbGeAlD
Nicotine—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.000313	0.00434	CcSEcCtD
Nicotine—CYP2D6—hindbrain—amyotrophic lateral sclerosis	0.000306	0.00432	CbGeAlD
Nicotine—CHRFAM7A—nervous system—amyotrophic lateral sclerosis	0.000304	0.00429	CbGeAlD
Nicotine—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.000303	0.00419	CcSEcCtD
Nicotine—CHRNB2—brain—amyotrophic lateral sclerosis	0.000297	0.00418	CbGeAlD
Nicotine—MAOA—brainstem—amyotrophic lateral sclerosis	0.000295	0.00416	CbGeAlD
Nicotine—CHRFAM7A—central nervous system—amyotrophic lateral sclerosis	0.000293	0.00413	CbGeAlD
Nicotine—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.000291	0.00403	CcSEcCtD
Nicotine—Rash—Riluzole—amyotrophic lateral sclerosis	0.000289	0.004	CcSEcCtD
Nicotine—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.000288	0.00399	CcSEcCtD
Nicotine—CHRNA4—spinal cord—amyotrophic lateral sclerosis	0.000288	0.00406	CbGeAlD
Nicotine—CHRNA3—brain—amyotrophic lateral sclerosis	0.000288	0.00406	CbGeAlD
Nicotine—Headache—Riluzole—amyotrophic lateral sclerosis	0.000287	0.00397	CcSEcCtD
Nicotine—Nausea—Riluzole—amyotrophic lateral sclerosis	0.000272	0.00376	CcSEcCtD
Nicotine—CHRNA2—brain—amyotrophic lateral sclerosis	0.000267	0.00377	CbGeAlD
Nicotine—SLC22A4—spinal cord—amyotrophic lateral sclerosis	0.000255	0.0036	CbGeAlD
Nicotine—CHRNA7—nervous system—amyotrophic lateral sclerosis	0.000246	0.00347	CbGeAlD
Nicotine—CHRNA4—nervous system—amyotrophic lateral sclerosis	0.000243	0.00342	CbGeAlD
Nicotine—MAOB—medulla oblongata—amyotrophic lateral sclerosis	0.000241	0.0034	CbGeAlD
Nicotine—CHRNA7—central nervous system—amyotrophic lateral sclerosis	0.000237	0.00334	CbGeAlD
Nicotine—CHRNA4—central nervous system—amyotrophic lateral sclerosis	0.000234	0.00329	CbGeAlD
Nicotine—CHRFAM7A—brain—amyotrophic lateral sclerosis	0.000233	0.00328	CbGeAlD
Nicotine—CYP2A6—cerebellum—amyotrophic lateral sclerosis	0.000231	0.00326	CbGeAlD
Nicotine—CHRNA4—cerebellum—amyotrophic lateral sclerosis	0.000228	0.00322	CbGeAlD
Nicotine—MAOB—spinal cord—amyotrophic lateral sclerosis	0.000215	0.00303	CbGeAlD
Nicotine—MAOA—medulla oblongata—amyotrophic lateral sclerosis	0.000206	0.0029	CbGeAlD
Nicotine—SLC22A1—nervous system—amyotrophic lateral sclerosis	0.000205	0.00289	CbGeAlD
Nicotine—SLC22A4—cerebellum—amyotrophic lateral sclerosis	0.000203	0.00286	CbGeAlD
Nicotine—SLC22A1—central nervous system—amyotrophic lateral sclerosis	0.000197	0.00278	CbGeAlD
Nicotine—SLC22A3—nervous system—amyotrophic lateral sclerosis	0.000196	0.00276	CbGeAlD
Nicotine—CYP19A1—nervous system—amyotrophic lateral sclerosis	0.000193	0.00272	CbGeAlD
Nicotine—SLC22A5—medulla oblongata—amyotrophic lateral sclerosis	0.00019	0.00267	CbGeAlD
Nicotine—SLC22A3—central nervous system—amyotrophic lateral sclerosis	0.000189	0.00266	CbGeAlD
Nicotine—CHRNA7—brain—amyotrophic lateral sclerosis	0.000188	0.00265	CbGeAlD
Nicotine—CYP2A6—brain—amyotrophic lateral sclerosis	0.000188	0.00265	CbGeAlD
Nicotine—CYP19A1—central nervous system—amyotrophic lateral sclerosis	0.000185	0.00262	CbGeAlD
Nicotine—CHRNA4—brain—amyotrophic lateral sclerosis	0.000185	0.00261	CbGeAlD
Nicotine—MAOA—spinal cord—amyotrophic lateral sclerosis	0.000184	0.00259	CbGeAlD
Nicotine—MAOB—nervous system—amyotrophic lateral sclerosis	0.000181	0.00256	CbGeAlD
Nicotine—CYP2D6—brainstem—amyotrophic lateral sclerosis	0.000175	0.00247	CbGeAlD
Nicotine—MAOB—central nervous system—amyotrophic lateral sclerosis	0.000175	0.00246	CbGeAlD
Nicotine—MAOB—cerebellum—amyotrophic lateral sclerosis	0.000171	0.00241	CbGeAlD
Nicotine—SLC22A5—spinal cord—amyotrophic lateral sclerosis	0.000169	0.00238	CbGeAlD
Nicotine—SLC22A4—brain—amyotrophic lateral sclerosis	0.000165	0.00232	CbGeAlD
Nicotine—SLC22A1—brain—amyotrophic lateral sclerosis	0.000157	0.00221	CbGeAlD
Nicotine—MAOA—nervous system—amyotrophic lateral sclerosis	0.000155	0.00218	CbGeAlD
Nicotine—CYP2E1—medulla oblongata—amyotrophic lateral sclerosis	0.000155	0.00218	CbGeAlD
Nicotine—SLC22A3—brain—amyotrophic lateral sclerosis	0.00015	0.00211	CbGeAlD
Nicotine—MAOA—central nervous system—amyotrophic lateral sclerosis	0.000149	0.0021	CbGeAlD
Nicotine—CYP19A1—brain—amyotrophic lateral sclerosis	0.000147	0.00208	CbGeAlD
Nicotine—MAOA—cerebellum—amyotrophic lateral sclerosis	0.000146	0.00205	CbGeAlD
Nicotine—MAOB—brain—amyotrophic lateral sclerosis	0.000139	0.00195	CbGeAlD
Nicotine—CYP2E1—spinal cord—amyotrophic lateral sclerosis	0.000138	0.00194	CbGeAlD
Nicotine—SLC22A5—cerebellum—amyotrophic lateral sclerosis	0.000134	0.00189	CbGeAlD
Nicotine—CYP1A1—nervous system—amyotrophic lateral sclerosis	0.000127	0.0018	CbGeAlD
Nicotine—CYP2B6—nervous system—amyotrophic lateral sclerosis	0.000124	0.00174	CbGeAlD
Nicotine—CYP1A1—central nervous system—amyotrophic lateral sclerosis	0.000123	0.00173	CbGeAlD
Nicotine—CYP2B6—central nervous system—amyotrophic lateral sclerosis	0.000119	0.00168	CbGeAlD
Nicotine—MAOA—brain—amyotrophic lateral sclerosis	0.000118	0.00167	CbGeAlD
Nicotine—CYP2E1—nervous system—amyotrophic lateral sclerosis	0.000116	0.00164	CbGeAlD
Nicotine—CYP2E1—central nervous system—amyotrophic lateral sclerosis	0.000112	0.00158	CbGeAlD
Nicotine—CYP2E1—cerebellum—amyotrophic lateral sclerosis	0.000109	0.00154	CbGeAlD
Nicotine—SLC22A5—brain—amyotrophic lateral sclerosis	0.000109	0.00154	CbGeAlD
Nicotine—CYP2C8—brain—amyotrophic lateral sclerosis	0.000105	0.00149	CbGeAlD
Nicotine—CYP1A1—brain—amyotrophic lateral sclerosis	9.73e-05	0.00137	CbGeAlD
Nicotine—CYP2B6—brain—amyotrophic lateral sclerosis	9.46e-05	0.00133	CbGeAlD
Nicotine—CYP3A4—nervous system—amyotrophic lateral sclerosis	9.34e-05	0.00132	CbGeAlD
Nicotine—CYP2D6—nervous system—amyotrophic lateral sclerosis	9.19e-05	0.0013	CbGeAlD
Nicotine—CYP3A4—central nervous system—amyotrophic lateral sclerosis	8.99e-05	0.00127	CbGeAlD
Nicotine—CYP2E1—brain—amyotrophic lateral sclerosis	8.87e-05	0.00125	CbGeAlD
Nicotine—CYP2D6—central nervous system—amyotrophic lateral sclerosis	8.85e-05	0.00125	CbGeAlD
Nicotine—CYP2D6—cerebellum—amyotrophic lateral sclerosis	8.65e-05	0.00122	CbGeAlD
Nicotine—CYP2D6—brain—amyotrophic lateral sclerosis	7.03e-05	0.000991	CbGeAlD
Nicotine—CYP2C9—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	2.67e-05	0.000349	CbGpPWpGaD
Nicotine—CYP19A1—Metabolism—FIG4—amyotrophic lateral sclerosis	2.66e-05	0.000347	CbGpPWpGaD
Nicotine—CYP2A6—Metabolism—TPK1—amyotrophic lateral sclerosis	2.65e-05	0.000345	CbGpPWpGaD
Nicotine—CYP2A6—Metabolism—VAPB—amyotrophic lateral sclerosis	2.65e-05	0.000345	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	2.64e-05	0.000345	CbGpPWpGaD
Nicotine—SLC22A2—Metabolism—VAPA—amyotrophic lateral sclerosis	2.64e-05	0.000344	CbGpPWpGaD
Nicotine—CHAT—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.59e-05	0.000338	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	2.58e-05	0.000337	CbGpPWpGaD
Nicotine—CYP1A1—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	2.58e-05	0.000336	CbGpPWpGaD
Nicotine—SLC22A2—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	2.56e-05	0.000333	CbGpPWpGaD
Nicotine—SLC22A2—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	2.56e-05	0.000333	CbGpPWpGaD
Nicotine—CYP1A1—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	2.54e-05	0.000331	CbGpPWpGaD
Nicotine—SLC22A3—Metabolism—PLB1—amyotrophic lateral sclerosis	2.52e-05	0.000329	CbGpPWpGaD
Nicotine—MAOA—Metabolism—DAO—amyotrophic lateral sclerosis	2.47e-05	0.000321	CbGpPWpGaD
Nicotine—SLC22A1—Metabolism—VAPA—amyotrophic lateral sclerosis	2.46e-05	0.000321	CbGpPWpGaD
Nicotine—SLC22A2—Metabolism—SACM1L—amyotrophic lateral sclerosis	2.45e-05	0.00032	CbGpPWpGaD
Nicotine—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—amyotrophic lateral sclerosis	2.44e-05	0.000318	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	2.43e-05	0.000316	CbGpPWpGaD
Nicotine—CYP2A6—Metabolism—VAPA—amyotrophic lateral sclerosis	2.42e-05	0.000316	CbGpPWpGaD
Nicotine—CYP19A1—Metabolism—DAO—amyotrophic lateral sclerosis	2.41e-05	0.000314	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	2.4e-05	0.000313	CbGpPWpGaD
Nicotine—SLC22A1—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	2.38e-05	0.000311	CbGpPWpGaD
Nicotine—SLC22A1—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	2.38e-05	0.000311	CbGpPWpGaD
Nicotine—CHAT—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.38e-05	0.00031	CbGpPWpGaD
Nicotine—CYP2C8—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	2.36e-05	0.000308	CbGpPWpGaD
Nicotine—CYP2C8—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	2.33e-05	0.000304	CbGpPWpGaD
Nicotine—SLC22A3—Metabolism—GSR—amyotrophic lateral sclerosis	2.33e-05	0.000303	CbGpPWpGaD
Nicotine—CYP19A1—Integrated Breast Cancer Pathway—CASP3—amyotrophic lateral sclerosis	2.32e-05	0.000302	CbGpPWpGaD
Nicotine—MAOA—SIDS Susceptibility Pathways—CASP3—amyotrophic lateral sclerosis	2.31e-05	0.000302	CbGpPWpGaD
Nicotine—SLC22A2—Metabolism—FIG4—amyotrophic lateral sclerosis	2.31e-05	0.000301	CbGpPWpGaD
Nicotine—SLC22A1—Metabolism—SACM1L—amyotrophic lateral sclerosis	2.29e-05	0.000298	CbGpPWpGaD
Nicotine—CYP1A2—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	2.29e-05	0.000298	CbGpPWpGaD
Nicotine—SLC22A2—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	2.28e-05	0.000297	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	2.26e-05	0.000294	CbGpPWpGaD
Nicotine—MAOB—Metabolism—CHAT—amyotrophic lateral sclerosis	2.26e-05	0.000294	CbGpPWpGaD
Nicotine—CYP2A6—Metabolism—SACM1L—amyotrophic lateral sclerosis	2.25e-05	0.000294	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	2.23e-05	0.00029	CbGpPWpGaD
Nicotine—CYP2A13—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.2e-05	0.000287	CbGpPWpGaD
Nicotine—SLC22A1—Metabolism—FIG4—amyotrophic lateral sclerosis	2.15e-05	0.00028	CbGpPWpGaD
Nicotine—CYP2B6—Metabolism—VAPB—amyotrophic lateral sclerosis	2.14e-05	0.000279	CbGpPWpGaD
Nicotine—CYP2B6—Metabolism—TPK1—amyotrophic lateral sclerosis	2.14e-05	0.000279	CbGpPWpGaD
Nicotine—SLC22A1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	2.12e-05	0.000277	CbGpPWpGaD
Nicotine—CYP2A6—Metabolism—FIG4—amyotrophic lateral sclerosis	2.12e-05	0.000276	CbGpPWpGaD
Nicotine—CYP2C19—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	2.11e-05	0.000275	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—VAPB—amyotrophic lateral sclerosis	2.09e-05	0.000273	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—TPK1—amyotrophic lateral sclerosis	2.09e-05	0.000273	CbGpPWpGaD
Nicotine—SLC22A2—Metabolism—DAO—amyotrophic lateral sclerosis	2.09e-05	0.000272	CbGpPWpGaD
Nicotine—CYP2C19—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	2.08e-05	0.000271	CbGpPWpGaD
Nicotine—CYP2A13—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.02e-05	0.000264	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	1.99e-05	0.000259	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—VAPB—amyotrophic lateral sclerosis	1.97e-05	0.000257	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—TPK1—amyotrophic lateral sclerosis	1.97e-05	0.000257	CbGpPWpGaD
Nicotine—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	1.97e-05	0.000256	CbGpPWpGaD
Nicotine—MAOA—SIDS Susceptibility Pathways—VEGFA—amyotrophic lateral sclerosis	1.96e-05	0.000256	CbGpPWpGaD
Nicotine—CHAT—Metabolism—APOE—amyotrophic lateral sclerosis	1.96e-05	0.000255	CbGpPWpGaD
Nicotine—CYP2B6—Metabolism—VAPA—amyotrophic lateral sclerosis	1.95e-05	0.000255	CbGpPWpGaD
Nicotine—SLC22A1—Metabolism—DAO—amyotrophic lateral sclerosis	1.94e-05	0.000253	CbGpPWpGaD
Nicotine—CYP2D6—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	1.94e-05	0.000253	CbGpPWpGaD
Nicotine—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—amyotrophic lateral sclerosis	1.92e-05	0.000251	CbGpPWpGaD
Nicotine—CYP2C9—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	1.92e-05	0.00025	CbGpPWpGaD
Nicotine—CYP2A6—Metabolism—DAO—amyotrophic lateral sclerosis	1.91e-05	0.00025	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—VAPA—amyotrophic lateral sclerosis	1.91e-05	0.00025	CbGpPWpGaD
Nicotine—CYP2D6—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	1.91e-05	0.000249	CbGpPWpGaD
Nicotine—SLC22A3—Metabolism—CHAT—amyotrophic lateral sclerosis	1.91e-05	0.000249	CbGpPWpGaD
Nicotine—CYP2C9—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	1.9e-05	0.000247	CbGpPWpGaD
Nicotine—MAOA—Metabolism—PLB1—amyotrophic lateral sclerosis	1.87e-05	0.000244	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	1.84e-05	0.00024	CbGpPWpGaD
Nicotine—CYP19A1—Metabolism—PLB1—amyotrophic lateral sclerosis	1.82e-05	0.000238	CbGpPWpGaD
Nicotine—CYP2B6—Metabolism—SACM1L—amyotrophic lateral sclerosis	1.82e-05	0.000237	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	1.81e-05	0.000236	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—VAPB—amyotrophic lateral sclerosis	1.81e-05	0.000236	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—TPK1—amyotrophic lateral sclerosis	1.81e-05	0.000236	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—VAPA—amyotrophic lateral sclerosis	1.8e-05	0.000235	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—SACM1L—amyotrophic lateral sclerosis	1.78e-05	0.000232	CbGpPWpGaD
Nicotine—MAOA—Metabolism—GSR—amyotrophic lateral sclerosis	1.73e-05	0.000225	CbGpPWpGaD
Nicotine—CYP2B6—Metabolism—FIG4—amyotrophic lateral sclerosis	1.71e-05	0.000223	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	1.69e-05	0.00022	CbGpPWpGaD
Nicotine—CYP19A1—Metabolism—GSR—amyotrophic lateral sclerosis	1.68e-05	0.000219	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—SACM1L—amyotrophic lateral sclerosis	1.68e-05	0.000219	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—FIG4—amyotrophic lateral sclerosis	1.67e-05	0.000218	CbGpPWpGaD
Nicotine—CYP2A13—Metabolism—APOE—amyotrophic lateral sclerosis	1.67e-05	0.000217	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—VAPA—amyotrophic lateral sclerosis	1.65e-05	0.000216	CbGpPWpGaD
Nicotine—CYP1A2—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	1.64e-05	0.000214	CbGpPWpGaD
Nicotine—CYP1A2—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	1.62e-05	0.000211	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—VAPB—amyotrophic lateral sclerosis	1.61e-05	0.00021	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—TPK1—amyotrophic lateral sclerosis	1.61e-05	0.00021	CbGpPWpGaD
Nicotine—SLC22A2—Metabolism—PLB1—amyotrophic lateral sclerosis	1.58e-05	0.000206	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—FIG4—amyotrophic lateral sclerosis	1.58e-05	0.000206	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	1.55e-05	0.000202	CbGpPWpGaD
Nicotine—CYP2B6—Metabolism—DAO—amyotrophic lateral sclerosis	1.54e-05	0.000201	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—SACM1L—amyotrophic lateral sclerosis	1.54e-05	0.000201	CbGpPWpGaD
Nicotine—CYP19A1—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	1.53e-05	0.0002	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—DAO—amyotrophic lateral sclerosis	1.51e-05	0.000197	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	1.51e-05	0.000196	CbGpPWpGaD
Nicotine—CYP19A1—Integrated Breast Cancer Pathway—TP53—amyotrophic lateral sclerosis	1.49e-05	0.000194	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—TPK1—amyotrophic lateral sclerosis	1.49e-05	0.000194	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—VAPB—amyotrophic lateral sclerosis	1.49e-05	0.000194	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—VAPA—amyotrophic lateral sclerosis	1.48e-05	0.000193	CbGpPWpGaD
Nicotine—SLC22A1—Metabolism—PLB1—amyotrophic lateral sclerosis	1.47e-05	0.000192	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—VAPB—amyotrophic lateral sclerosis	1.47e-05	0.000192	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—TPK1—amyotrophic lateral sclerosis	1.47e-05	0.000192	CbGpPWpGaD
Nicotine—SLC22A2—Metabolism—GSR—amyotrophic lateral sclerosis	1.46e-05	0.00019	CbGpPWpGaD
Nicotine—CYP2A6—Metabolism—PLB1—amyotrophic lateral sclerosis	1.45e-05	0.000189	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—FIG4—amyotrophic lateral sclerosis	1.45e-05	0.000189	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—DAO—amyotrophic lateral sclerosis	1.43e-05	0.000186	CbGpPWpGaD
Nicotine—MAOA—Metabolism—CHAT—amyotrophic lateral sclerosis	1.42e-05	0.000185	CbGpPWpGaD
Nicotine—CYP19A1—Metabolism—CHAT—amyotrophic lateral sclerosis	1.38e-05	0.00018	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—SACM1L—amyotrophic lateral sclerosis	1.37e-05	0.000179	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	1.37e-05	0.000179	CbGpPWpGaD
Nicotine—SLC22A1—Metabolism—GSR—amyotrophic lateral sclerosis	1.36e-05	0.000177	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—VAPA—amyotrophic lateral sclerosis	1.36e-05	0.000177	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—VAPA—amyotrophic lateral sclerosis	1.35e-05	0.000176	CbGpPWpGaD
Nicotine—CHAT—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.34e-05	0.000175	CbGpPWpGaD
Nicotine—CYP2A6—Metabolism—GSR—amyotrophic lateral sclerosis	1.34e-05	0.000175	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—DAO—amyotrophic lateral sclerosis	1.31e-05	0.00017	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—FIG4—amyotrophic lateral sclerosis	1.29e-05	0.000168	CbGpPWpGaD
Nicotine—CYP3A4—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	1.27e-05	0.000165	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—SACM1L—amyotrophic lateral sclerosis	1.26e-05	0.000165	CbGpPWpGaD
Nicotine—CYP19A1—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	1.26e-05	0.000164	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—VAPB—amyotrophic lateral sclerosis	1.26e-05	0.000164	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—TPK1—amyotrophic lateral sclerosis	1.26e-05	0.000164	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—SACM1L—amyotrophic lateral sclerosis	1.25e-05	0.000163	CbGpPWpGaD
Nicotine—CYP3A4—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	1.25e-05	0.000163	CbGpPWpGaD
Nicotine—MAOB—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.21e-05	0.000158	CbGpPWpGaD
Nicotine—SLC22A2—Metabolism—CHAT—amyotrophic lateral sclerosis	1.2e-05	0.000156	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—FIG4—amyotrophic lateral sclerosis	1.19e-05	0.000155	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—FIG4—amyotrophic lateral sclerosis	1.18e-05	0.000153	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	1.17e-05	0.000153	CbGpPWpGaD
Nicotine—CYP2B6—Metabolism—PLB1—amyotrophic lateral sclerosis	1.17e-05	0.000153	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—DAO—amyotrophic lateral sclerosis	1.17e-05	0.000152	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—VAPA—amyotrophic lateral sclerosis	1.15e-05	0.00015	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—PLB1—amyotrophic lateral sclerosis	1.15e-05	0.000149	CbGpPWpGaD
Nicotine—CYP2A13—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.14e-05	0.000149	CbGpPWpGaD
Nicotine—SLC22A1—Metabolism—CHAT—amyotrophic lateral sclerosis	1.12e-05	0.000146	CbGpPWpGaD
Nicotine—MAOB—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.12e-05	0.000145	CbGpPWpGaD
Nicotine—CYP2A6—Metabolism—CHAT—amyotrophic lateral sclerosis	1.1e-05	0.000143	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—PLB1—amyotrophic lateral sclerosis	1.08e-05	0.000141	CbGpPWpGaD
Nicotine—CYP2B6—Metabolism—GSR—amyotrophic lateral sclerosis	1.08e-05	0.000141	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—DAO—amyotrophic lateral sclerosis	1.07e-05	0.00014	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—SACM1L—amyotrophic lateral sclerosis	1.07e-05	0.000139	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—DAO—amyotrophic lateral sclerosis	1.06e-05	0.000139	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—GSR—amyotrophic lateral sclerosis	1.06e-05	0.000138	CbGpPWpGaD
Nicotine—SLC22A3—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.03e-05	0.000134	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—FIG4—amyotrophic lateral sclerosis	1.01e-05	0.000131	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—GSR—amyotrophic lateral sclerosis	9.98e-06	0.00013	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—PLB1—amyotrophic lateral sclerosis	9.91e-06	0.000129	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—TPK1—amyotrophic lateral sclerosis	9.71e-06	0.000127	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—VAPB—amyotrophic lateral sclerosis	9.71e-06	0.000127	CbGpPWpGaD
Nicotine—SLC22A3—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	9.43e-06	0.000123	CbGpPWpGaD
Nicotine—MAOB—Metabolism—APOE—amyotrophic lateral sclerosis	9.17e-06	0.00012	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—GSR—amyotrophic lateral sclerosis	9.15e-06	0.000119	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—DAO—amyotrophic lateral sclerosis	9.1e-06	0.000119	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	9.09e-06	0.000118	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—VAPA—amyotrophic lateral sclerosis	8.88e-06	0.000116	CbGpPWpGaD
Nicotine—CYP2B6—Metabolism—CHAT—amyotrophic lateral sclerosis	8.87e-06	0.000116	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—PLB1—amyotrophic lateral sclerosis	8.85e-06	0.000115	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—CHAT—amyotrophic lateral sclerosis	8.69e-06	0.000113	CbGpPWpGaD
Nicotine—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	8.64e-06	0.000113	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	8.33e-06	0.000109	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—SACM1L—amyotrophic lateral sclerosis	8.26e-06	0.000108	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—CHAT—amyotrophic lateral sclerosis	8.19e-06	0.000107	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—GSR—amyotrophic lateral sclerosis	8.17e-06	0.000106	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—PLB1—amyotrophic lateral sclerosis	8.14e-06	0.000106	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—PLB1—amyotrophic lateral sclerosis	8.07e-06	0.000105	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—FIG4—amyotrophic lateral sclerosis	7.76e-06	0.000101	CbGpPWpGaD
Nicotine—SLC22A3—Metabolism—APOE—amyotrophic lateral sclerosis	7.76e-06	0.000101	CbGpPWpGaD
Nicotine—MAOA—Metabolism—GSTP1—amyotrophic lateral sclerosis	7.61e-06	9.92e-05	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—CHAT—amyotrophic lateral sclerosis	7.51e-06	9.79e-05	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—GSR—amyotrophic lateral sclerosis	7.51e-06	9.79e-05	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	7.48e-06	9.75e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—GSR—amyotrophic lateral sclerosis	7.45e-06	9.7e-05	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	7.44e-06	9.69e-05	CbGpPWpGaD
Nicotine—CYP19A1—Metabolism—GSTP1—amyotrophic lateral sclerosis	7.43e-06	9.68e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—DAO—amyotrophic lateral sclerosis	7.02e-06	9.15e-05	CbGpPWpGaD
Nicotine—MAOA—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	7e-06	9.12e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—PLB1—amyotrophic lateral sclerosis	6.89e-06	8.99e-05	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	6.85e-06	8.93e-05	CbGpPWpGaD
Nicotine—CYP19A1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	6.82e-06	8.89e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	6.78e-06	8.84e-05	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—CHAT—amyotrophic lateral sclerosis	6.71e-06	8.74e-05	CbGpPWpGaD
Nicotine—SLC22A2—Metabolism—GSTP1—amyotrophic lateral sclerosis	6.44e-06	8.39e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—GSR—amyotrophic lateral sclerosis	6.36e-06	8.29e-05	CbGpPWpGaD
Nicotine—MAOB—Metabolism—PTGS2—amyotrophic lateral sclerosis	6.29e-06	8.19e-05	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—CHAT—amyotrophic lateral sclerosis	6.17e-06	8.04e-05	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	6.12e-06	7.97e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—CHAT—amyotrophic lateral sclerosis	6.11e-06	7.97e-05	CbGpPWpGaD
Nicotine—SLC22A1—Metabolism—GSTP1—amyotrophic lateral sclerosis	6e-06	7.82e-05	CbGpPWpGaD
Nicotine—SLC22A2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	5.92e-06	7.71e-05	CbGpPWpGaD
Nicotine—CYP2A6—Metabolism—GSTP1—amyotrophic lateral sclerosis	5.91e-06	7.7e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	5.79e-06	7.55e-05	CbGpPWpGaD
Nicotine—MAOA—Metabolism—APOE—amyotrophic lateral sclerosis	5.76e-06	7.5e-05	CbGpPWpGaD
Nicotine—CYP19A1—Metabolism—APOE—amyotrophic lateral sclerosis	5.61e-06	7.32e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	5.58e-06	7.27e-05	CbGpPWpGaD
Nicotine—SLC22A1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	5.51e-06	7.19e-05	CbGpPWpGaD
Nicotine—CYP2A6—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	5.43e-06	7.08e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—PLB1—amyotrophic lateral sclerosis	5.32e-06	6.93e-05	CbGpPWpGaD
Nicotine—SLC22A3—Metabolism—PTGS2—amyotrophic lateral sclerosis	5.32e-06	6.93e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—CHAT—amyotrophic lateral sclerosis	5.22e-06	6.81e-05	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	5.12e-06	6.68e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—GSR—amyotrophic lateral sclerosis	4.91e-06	6.4e-05	CbGpPWpGaD
Nicotine—SLC22A2—Metabolism—APOE—amyotrophic lateral sclerosis	4.87e-06	6.35e-05	CbGpPWpGaD
Nicotine—CYP2B6—Metabolism—GSTP1—amyotrophic lateral sclerosis	4.77e-06	6.22e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	4.77e-06	6.21e-05	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	4.7e-06	6.12e-05	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—GSTP1—amyotrophic lateral sclerosis	4.67e-06	6.09e-05	CbGpPWpGaD
Nicotine—SLC22A1—Metabolism—APOE—amyotrophic lateral sclerosis	4.54e-06	5.91e-05	CbGpPWpGaD
Nicotine—CYP2A6—Metabolism—APOE—amyotrophic lateral sclerosis	4.47e-06	5.83e-05	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—GSTP1—amyotrophic lateral sclerosis	4.4e-06	5.74e-05	CbGpPWpGaD
Nicotine—CYP2B6—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	4.38e-06	5.71e-05	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	4.29e-06	5.59e-05	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	4.19e-06	5.46e-05	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	4.05e-06	5.27e-05	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—GSTP1—amyotrophic lateral sclerosis	4.04e-06	5.26e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—CHAT—amyotrophic lateral sclerosis	4.03e-06	5.26e-05	CbGpPWpGaD
Nicotine—MAOA—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.94e-06	5.14e-05	CbGpPWpGaD
Nicotine—CYP19A1—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.85e-06	5.01e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	3.82e-06	4.98e-05	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	3.71e-06	4.84e-05	CbGpPWpGaD
Nicotine—CYP2B6—Metabolism—APOE—amyotrophic lateral sclerosis	3.61e-06	4.7e-05	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—GSTP1—amyotrophic lateral sclerosis	3.6e-06	4.7e-05	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—APOE—amyotrophic lateral sclerosis	3.53e-06	4.6e-05	CbGpPWpGaD
Nicotine—SLC22A2—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.34e-06	4.35e-05	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—APOE—amyotrophic lateral sclerosis	3.33e-06	4.34e-05	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—GSTP1—amyotrophic lateral sclerosis	3.31e-06	4.32e-05	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	3.31e-06	4.32e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—GSTP1—amyotrophic lateral sclerosis	3.29e-06	4.28e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	3.27e-06	4.26e-05	CbGpPWpGaD
Nicotine—SLC22A1—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.11e-06	4.05e-05	CbGpPWpGaD
Nicotine—CYP2A6—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.06e-06	3.99e-05	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—APOE—amyotrophic lateral sclerosis	3.05e-06	3.98e-05	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	3.05e-06	3.97e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	3.02e-06	3.94e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.81e-06	3.66e-05	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—APOE—amyotrophic lateral sclerosis	2.72e-06	3.55e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.58e-06	3.36e-05	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—APOE—amyotrophic lateral sclerosis	2.51e-06	3.27e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—APOE—amyotrophic lateral sclerosis	2.48e-06	3.24e-05	CbGpPWpGaD
Nicotine—CYP2B6—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.47e-06	3.22e-05	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.42e-06	3.15e-05	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.28e-06	2.97e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.17e-06	2.82e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—APOE—amyotrophic lateral sclerosis	2.12e-06	2.77e-05	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.09e-06	2.73e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.99e-06	2.6e-05	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.87e-06	2.43e-05	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.72e-06	2.24e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.7e-06	2.22e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—APOE—amyotrophic lateral sclerosis	1.64e-06	2.14e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.45e-06	1.9e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.12e-06	1.46e-05	CbGpPWpGaD
